SAB Biotherapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
5.40
|
|
Average Rating
|
4.75
|
|
# Strong Buys
|
3
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.16
|
-0.16
|
0.00
|
0.00%
|
|
2022-06-30
|
-0.17
|
-0.11
|
0.06
|
35.29%
|
|
2022-03-31
|
-0.16
|
0.02
|
0.18
|
112.50%
|
|
2021-12-31
|
-0.11
|
-0.66
|
-0.55
|
-500.00%
|
|
2021-09-30
|
-0.09
|
-0.02
|
0.07
|
77.78%
|
|
2021-06-30
|
0.00
|
-0.03
|
0.00
|
0.00%
|
|
2021-03-31
|
0.00
|
0.84
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.25
|
|
2021-12-31
|
0.13
|